Study of epileptiform activity in cerebral ganglion of mud crab Scylla serrata.
An attempt is made to induce in mud crab (Scylla serrata) epileptiform activities that resemble the generalized epileptic seizures. Cerebral ganglion of crab was exposed in situ, to a convulsant drug pentylenetetrazole (PTZ) 100 mM, for induction of seizures. Also, crabs were pretreated with antiepileptic drug viz sodium valproate (120 μmol/l) to inhibit epileptiform activities. The surface electrical discharges of cerebral ganglion were recorded using Unkelscope (MIT, USA) in control as well as experimental animals. The cerebral ganglion of crab showed a pattern of high cerebral electrical discharges after PTZ treatment compared to control. The sodium valproate promoted sedative action in control and prevented PTZ-mediated epileptiform discharges. Glutamate and GABA contents in cerebral ganglion were assayed. Glutamate level increased (31.45%) during PTZ treatment with concomitant decrease (43.93%) in GABA. Sodium valproate had no effect on glutamate concentration, but it decreased GABA by 24.75%. The present study shows that epileptiform activities can be induced in crabs.
Department of Zoology, Goa University, Taleigao Plateau, India.
K K
KK
Therisa
P V
PV
Desai
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D003386:Brachyura; D003292:Convulsants / Q000494:pharmacology; D004195:Disease Models, Animal; D004827:Epilepsy / Q000139:chemically induced* / Q000188:drug therapy; D017952:Ganglia, Invertebrate / Q000033:anatomy & histology / Q000187:drug effects*; D018698:Glutamic Acid / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D010433:Pentylenetetrazole / Q000009:adverse effects*; D014635:Valproic Acid / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000187:drug effects / Q000378:metabolism
D000927:Anticonvulsants; D003292:Convulsants; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D010433:Pentylenetetrazole
Food Chem Toxicol. 2001 Dec;39(12):1285-9
11696403
Brain Res. 1987 Sep 1;419(1-2):55-64
2445428
Neurosci Lett. 1992 Dec 7;147(2):155-8
1283455
J Ethnopharmacol. 2006 Mar 8;104(1-2):278-82
16226415
Adv Neurol. 1986;44:235-61
2422894
Exp Brain Res. 1986;65(1):1-10
3026832
Neurosci Lett. 1994 Nov 7;181(1-2):161-4
7534891
Hum Mol Genet. 2004 Sep 15;13(18):2043-59
15254012
Jpn J Physiol. 1973 Jun;23(3):261-74
4543109
Neurochem Int. 1999 Jan;34(1):23-31
10100193
Brain Res. 1996 May 25;722(1-2):59-70
8813350
J Comp Physiol A. 1995 Sep;177(3):321-33
7643321
Epilepsy Res. 2009 Jan;83(1):66-72
19013768
Neurology. 1994 Nov;44(11 Suppl 8):S14-23
7970002
Acta Biol Hung. 1992;43(1-4):79-88
1299133
Epilepsia. 1973 Dec;14(4):397-408
4521096
Epilepsy Res. 1991 Oct;10(1):55-61
1790773
Comp Biochem Physiol C Comp Pharmacol Toxicol. 1991;99(3):579-87
1685437
Brain Res Bull. 2009 Mar 30;78(6):299-305
19026723
Nat Neurosci. 2003 Oct;6(10):1079-85
14502289
Proc Natl Acad Sci U S A. 1989 Jan;86(1):402-6
2643105
Brain Res. 1991 Jul 5;553(1):27-32
1718540
Epilepsia. 1999 Nov;40(11):1512-22
10565577
Restor Neurol Neurosci. 1998;13(1-2):25-39
12671285
Ann Neurol. 1991 Apr;29(4):356-63
1929206
Neuron. 1988 Oct;1(8):623-34
2908446
Science. 1963 Mar 1;139(3557):840-2
13948714
Exp Neurol. 1964 Apr;9:286-304
14145629